These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15956098)

  • 1. Ciprofloxacin resistance among human Campylobacter isolates 1991-2004: an update.
    Dingle KE; Clarke L; Bowler IC
    J Antimicrob Chemother; 2005 Aug; 56(2):435-7. PubMed ID: 15956098
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative contribution of target gene mutation and efflux to varying quinolone resistance in Irish Campylobacter isolates.
    Corcoran D; Quinn T; Cotter L; Fanning S
    FEMS Microbiol Lett; 2005 Dec; 253(1):39-46. PubMed ID: 16213669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genotypic anti-microbial resistance profiles of campylobacters from untreated feedlot cattle and their environment.
    Minihan D; Whyte P; O'mahony M; Cowley D; O'halloran F; Corcoran D; Fanning S; Collins JD
    J Vet Med B Infect Dis Vet Public Health; 2006 May; 53(4):181-7. PubMed ID: 16629986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.
    Rodríguez-Avial I; Rodríguez-Avial C; López O; Culebras E; Picazo JJ
    Int J Antimicrob Agents; 2006 Apr; 27(4):303-6. PubMed ID: 16540293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin-resistant Campylobacter.
    Menzies F; McDowell S; Neill S
    Vet Rec; 2003 Jan; 152(3):91; author reply 91. PubMed ID: 12570315
    [No Abstract]   [Full Text] [Related]  

  • 6. Ciprofloxacin resistance does not affect duration of domestically acquired campylobacteriosis.
    Cox LA; Copeland D; Vaughn M
    J Infect Dis; 2005 May; 191(9):1565-6; author reply 1566-7. PubMed ID: 15809917
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA withdraws approval of two poultry drugs.
    FDA Consum; 2001; 35(4):5. PubMed ID: 11692891
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta.
    Johnson JY; McMullen LM; Hasselback P; Louie M; Jhangri G; Saunders LD
    Epidemiol Infect; 2008 Jul; 136(7):903-12. PubMed ID: 17678560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection.
    Evans MR; Northey G; Sarvotham TS; Rigby CJ; Hopkins AL; Thomas DR
    Clin Infect Dis; 2009 Jun; 48(11):1500-6. PubMed ID: 19400688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales.
    Evans MR; Northey G; Sarvotham TS; Hopkins AL; Rigby CJ; Thomas DR
    J Antimicrob Chemother; 2009 Aug; 64(2):424-7. PubMed ID: 19454522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance trends and animal drug use: a retrospective analysis.
    Radostits OM
    Int J Infect Dis; 2004 May; 8(3):187-9; author reply 190-2. PubMed ID: 15109595
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates.
    Feodoroff FB; Lauhio AR; Sarna SJ; Hänninen ML; Rautelin HI
    Clin Microbiol Infect; 2009 Feb; 15(2):188-92. PubMed ID: 19154485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
    Pasquali F; Lucchi A; Manfreda G
    Int J Antimicrob Agents; 2008 May; 31(5):500-2. PubMed ID: 18329250
    [No Abstract]   [Full Text] [Related]  

  • 14. Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle.
    Jesse TW; Englen MD; Pittenger-Alley LG; Fedorka-Cray PJ
    J Appl Microbiol; 2006 Apr; 100(4):682-8. PubMed ID: 16553723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection.
    Nelson JM; Smith KE; Vugia DJ; Rabatsky-Ehr T; Segler SD; Kassenborg HD; Zansky SM; Joyce K; Marano N; Hoekstra RM; Angulo FJ
    J Infect Dis; 2004 Sep; 190(6):1150-7. PubMed ID: 15319866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and antimicrobial resistance among Campylobacter spp. in Louisiana retail chickens after the enrofloxacin ban.
    Han F; Lestari SI; Pu S; Ge B
    Foodborne Pathog Dis; 2009 Mar; 6(2):163-71. PubMed ID: 19099357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance of Campylobacter coli isolates from swine.
    Ekkapobyotin C; Padungtod P; Chuanchuen R
    Int J Food Microbiol; 2008 Dec; 128(2):325-8. PubMed ID: 18945505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure.
    Yan M; Sahin O; Lin J; Zhang Q
    J Antimicrob Chemother; 2006 Dec; 58(6):1154-9. PubMed ID: 17023497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of disc diffusion and epsilometer (E-test) testing techniques to determine antimicrobial susceptibility of Campylobacter isolates of food and human clinical origin.
    McGill K; Kelly L; Madden RH; Moran L; Carroll C; O'Leary A; Moore JE; McNamara E; O'Mahony M; Fanning S; Whyte P
    J Microbiol Methods; 2009 Nov; 79(2):238-41. PubMed ID: 19793541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter spp. and their antimicrobial resistance patterns in poultry: an epidemiological survey study in Turkey.
    Cokal Y; Caner V; Sen A; Cetin C; Karagenc N
    Zoonoses Public Health; 2009 Apr; 56(3):105-10. PubMed ID: 18811676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.